vimarsana.com

AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript October 4, 2023 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.14. Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2024 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the […]

Related Keywords

Canaccord Genuity ,Steve Trowbridge ,Jim Clemmer ,Jayson Bedford ,Raymond James ,Matt Mishan ,Steve Lichtman ,John Young , ,Angiodynamic President ,Chief Executive ,Angiodynamic Executive Vice President ,Chief Financial Officer ,Med Tech ,Med Device ,Scientific Symposium ,Solero Microwave Ablation ,Executive Vice President ,Investor Relations ,Breakthrough Device Designation ,Bear Market Stocks To Buy Now ,Consumed By Longest Living People Every ,Clinical Symposium ,Angiodynamics ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.